Pernix Therapeutics (NASDAQ: PTX) disclosed in an SEC filing:5.02 Departure of Directors or Principal Officers; Election ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE